PIETRANGELO, Antonello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.581
EU - Europa 19.067
AS - Asia 18.076
SA - Sud America 2.692
Continente sconosciuto - Info sul continente non disponibili 433
AF - Africa 404
OC - Oceania 73
AN - Antartide 1
Totale 84.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 42.450
SG - Singapore 5.290
CN - Cina 5.001
GB - Regno Unito 4.821
IT - Italia 4.592
SE - Svezia 3.398
BR - Brasile 2.096
HK - Hong Kong 1.923
VN - Vietnam 1.779
DE - Germania 1.471
FI - Finlandia 1.246
BD - Bangladesh 977
KR - Corea 868
UA - Ucraina 747
FR - Francia 710
RU - Federazione Russa 666
CA - Canada 570
TR - Turchia 527
IN - India 406
BG - Bulgaria 304
NL - Olanda 293
ID - Indonesia 232
AR - Argentina 207
MX - Messico 170
JP - Giappone 157
IQ - Iraq 141
PL - Polonia 109
ZA - Sudafrica 106
BE - Belgio 93
ES - Italia 91
PK - Pakistan 88
IE - Irlanda 87
AE - Emirati Arabi Uniti 85
CO - Colombia 84
CR - Costa Rica 82
EC - Ecuador 79
MY - Malesia 75
IL - Israele 72
LT - Lituania 68
AT - Austria 67
AU - Australia 65
CL - Cile 62
VE - Venezuela 62
JM - Giamaica 61
PH - Filippine 53
EG - Egitto 52
RO - Romania 50
HN - Honduras 42
CH - Svizzera 40
UZ - Uzbekistan 40
IR - Iran 39
MA - Marocco 39
SA - Arabia Saudita 39
TH - Thailandia 38
DZ - Algeria 34
TT - Trinidad e Tobago 34
KE - Kenya 31
TN - Tunisia 31
PY - Paraguay 30
SC - Seychelles 29
CZ - Repubblica Ceca 28
PE - Perù 27
PR - Porto Rico 27
BO - Bolivia 26
GT - Guatemala 26
JO - Giordania 25
SV - El Salvador 25
NP - Nepal 24
GR - Grecia 22
OM - Oman 22
NI - Nicaragua 21
KZ - Kazakistan 20
PT - Portogallo 20
TW - Taiwan 20
AZ - Azerbaigian 18
GP - Guadalupe 18
ET - Etiopia 17
HU - Ungheria 17
SI - Slovenia 17
AL - Albania 15
RS - Serbia 15
UY - Uruguay 14
LB - Libano 13
PS - Palestinian Territory 13
SK - Slovacchia (Repubblica Slovacca) 13
CW - ???statistics.table.value.countryCode.CW??? 12
DK - Danimarca 11
EE - Estonia 11
NG - Nigeria 11
PA - Panama 11
SY - Repubblica araba siriana 11
AM - Armenia 10
BY - Bielorussia 10
CI - Costa d'Avorio 10
DO - Repubblica Dominicana 10
EU - Europa 10
KG - Kirghizistan 9
SN - Senegal 9
CY - Cipro 8
GE - Georgia 8
Totale 83.753
Salva come PNG Salva come JPEG
Città #
Ashburn 5.179
Fairfield 3.381
Southend 3.205
Singapore 3.203
Santa Clara 3.038
Woodbridge 2.262
San Jose 2.109
Hong Kong 1.893
Hefei 1.859
Stockholm 1.817
Houston 1.813
Chandler 1.794
Jacksonville 1.395
Council Bluffs 1.249
Seattle 1.174
Wilmington 1.162
Cambridge 1.054
Chicago 977
Ann Arbor 969
Dearborn 969
Helsinki 956
London 853
Nyköping 828
Beijing 810
Seoul 801
Los Angeles 732
Ho Chi Minh City 598
Modena 554
The Dalles 495
New York 463
Milan 439
Dallas 430
Hanoi 420
San Diego 386
Princeton 317
Sofia 280
Buffalo 278
Boardman 268
Rome 250
São Paulo 247
Eugene 237
Lauterbourg 231
Berlin 212
Izmir 204
Moscow 194
Shanghai 192
Munich 170
Des Moines 162
Bologna 160
Jakarta 154
Toronto 152
Phoenix 151
Columbus 149
Salt Lake City 148
Redwood City 145
Orem 122
Frankfurt am Main 115
Sunnyvale 115
Montreal 107
Tokyo 102
Atlanta 98
Amsterdam 93
Da Nang 89
Bremen 88
North Bergen 84
Warsaw 84
Philadelphia 82
Brooklyn 81
Naples 81
Falls Church 78
Reading 74
Brussels 72
Parma 72
San Francisco 71
Elk Grove Village 69
Ottawa 69
Denver 68
Porto Alegre 68
Tampa 66
Dublin 65
Chennai 64
Florence 62
Rio de Janeiro 62
Kent 61
Miami 60
Yalova 60
Haiphong 59
Mexico City 57
Nuremberg 57
San José 57
Washington 57
Baghdad 54
Paris 54
Johannesburg 53
Charlotte 52
Nanjing 52
Norwalk 51
Bari 49
Boston 49
Brasília 48
Totale 56.799
Salva come PNG Salva come JPEG
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.861
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 773
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 617
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 557
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB 538
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 533
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 522
Coproporphyrin excretion in healthy newborn babies 489
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 486
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 462
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 458
Non-HFE Hepatic Iron Overload. 455
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 452
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 452
Ferroportin disease: Pathogenesis, diagnosis and treatment 432
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 432
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 431
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 423
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 418
Hereditary hemochromatosis--a new look at an old disease. 414
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 414
Human macrophage ferroportin biology and the basis for the ferroportin disease 413
Primary hypoparathyroidism is common in adult patients with b-thalassemia and protect patients from osteoporosis. 412
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 411
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment 407
Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. 404
Association between celiac disease and idiopathic dilated cardiomyopathy: a case report. 404
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis. 395
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription 393
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 391
ER stress controls iron metabolism through induction of hepcidin. 389
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 388
3-hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo 376
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 376
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene 374
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 374
Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice 371
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 370
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression 370
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 367
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 366
Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. 365
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 364
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 363
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy 362
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 360
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 360
Duodenal ferritin synthesis in genetic hemochromatosis 359
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 358
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 357
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 357
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents 356
Haemochromatosis 356
Comorbidity does not mean clinical complexity: evidence from the RePoSI register 356
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 354
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 353
An unfortunate case of post-ERCP complications 350
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 349
VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS 348
Haptoglobin modifies the hemochromatosis phenotype in mice 348
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 348
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 346
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 345
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 344
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 344
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion 343
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 343
Heterogeneity of hemochromatosis in Italy 339
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 338
MOLECULAR AND CELLULAR ASPECTS OF IRON-INDUCED HEPATIC CIRRHOSIS IN RODENTS 332
Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y 330
DNA repair in lymphocytes from humans and rats with chronic iron overload. 330
Iron and steatohepatitis. 330
The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress 329
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 328
C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration 328
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload 325
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 325
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 323
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis 322
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 322
Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload. 317
Liver gene expression during chronic dietary iron overload in rats 317
THE BMP'S PATHWAY IN HEPCIDIN REGULATION DURING ENDOPLASMIC RETICULUM STRESS RESPONSE. 316
The impact of inherited thrombophilia on liver transplantation. 313
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 313
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 311
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes 310
Missed treatment in an Italian HBV infected patients cohort: HBV RER 310
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 310
Huh-7: a human hemochromatotic cell line. 308
Antioxidant activity of silybin in vivo during long-term iron overload in rats 308
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years since Hepcidin 307
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 306
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? 305
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 305
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 304
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene 303
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 302
Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum 301
Totale 39.025
Salva come PNG Salva come JPEG
Categoria #
all - tutte 310.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 310.231
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.732 0 0 0 0 223 271 393 295 619 436 861 634
2022/20235.388 612 563 348 504 647 824 114 592 645 86 244 209
2023/20243.601 169 221 511 298 529 273 301 425 133 188 192 361
2024/202512.875 675 150 341 856 2.182 1.813 773 698 1.227 768 1.768 1.624
2025/202626.539 1.709 1.253 2.283 2.289 2.710 2.089 3.031 1.244 4.417 2.305 1.654 1.555
2026/20279.072 976 2.258 2.102 3.177 559 0 0 0 0 0 0 0
Totale 84.327